| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |